Jain Global’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.1K Sell
46,552
-5,497
-11% -$10.3K ﹤0.01% 1139
2025
Q4
$124K Buy
+52,049
New +$142K ﹤0.01% 1088

Other funds holding HCAT

Jain Global's HCAT Position: Q1 2026 in Review

Jain Global reduced its Health Catalyst (HCAT) stake by 11% in Q1 2026, selling an estimated $10.3K and leaving 46,552 shares worth $59.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Jain Global first reported a position in HCAT in Q4 2025 and has held it in 2 quarters since. The position peaked at $124K in Q4 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Jain Global held 46,552 shares of Health Catalyst worth $59.1K as of Q1 2026.
  • Jain Global sold 5,497 Health Catalyst shares in Q1 2026, an estimated $10.3K.
  • Health Catalyst made up ﹤0.01% of Jain Global's portfolio in Q1 2026, its #1139 holding.
  • Jain Global first reported a position in Health Catalyst in Q4 2025 and has held it in 2 quarters since.
  • Jain Global's Health Catalyst position peaked at $124K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.